Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yomna I El-Gazzar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archiv Der Pharmazie|January 23, 2026
Targeting EGFR With Quinazoline-4-One/Chalcone Hybrids: Design, Synthesis, and Anticancer EvaluationYomna I El-Gazzar, Rasha Abdelhady, Nancy S Younis, et al.
Bioorganic Chemistry|September 3, 2017
Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling studyMenna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, et al.
Bioorganic Chemistry|June 5, 2018
Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling studyMenna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, et al.
Archiv Der Pharmazie|October 18, 2022
New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activityYomna I El-Gazzar, Heba R Ghaiad, Ahmed M El Kerdawy, et al.
Bioorganic Chemistry|May 13, 2017
Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitorsYomna I El-Gazzar, Hanan H Georgey, Shahenda M El-Messery, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archiv Der Pharmazie|January 23, 2026
Targeting EGFR With Quinazoline-4-One/Chalcone Hybrids: Design, Synthesis, and Anticancer EvaluationYomna I El-Gazzar, Rasha Abdelhady, Nancy S Younis, et al.
Bioorganic Chemistry|September 3, 2017
Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling studyMenna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, et al.
Bioorganic Chemistry|June 5, 2018
Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling studyMenna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, et al.
Archiv Der Pharmazie|October 18, 2022
New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activityYomna I El-Gazzar, Heba R Ghaiad, Ahmed M El Kerdawy, et al.
Bioorganic Chemistry|May 13, 2017
Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitorsYomna I El-Gazzar, Hanan H Georgey, Shahenda M El-Messery, et al.
Pageof 1